Human LILRB5 / CD85c / LIR-8 Protein
产品名称: Human LILRB5 / CD85c / LIR-8 Protein
英文名称: Human LILRB5 / CD85c / LIR-8 Protein
产品编号: CDC-H5220
产品价格: 0
产品产地: USA
品牌商标: ACROBiosystems
更新时间: null
使用范围: null
北京百普赛斯生物科技股份有限公司
- 联系人 :
- 地址 : 北京经济技术开发区宏达北路8号5号楼4层
- 邮编 : 100176
- 所在区域 : 北京
- 电话 : 点击查看
- 传真 : 点击查看
- 邮箱 : order.cn@acrobiosystems.com
分子量:42.7 kDa 纯度:>92% as determined by SDS-PAGE. 内毒素:Less than 1.0 EU per μg of the Human Serpin E2, His Tag by the LAL method. Buffer:20 mM NaAc, 100 mM NaCl, PH6.5 生物活性:Measured by its ability to inhibit trypsin cleavage of a fluorogenic peptide substrate, Mca - RPKPVE - Nval - WRK(Dnp) - NH2. 产品特性:Human Serpin E2, His Tag is fused with a polyhistidine tag at the C-terminus, and has a calculated MW of 42.7 kDa. The predicted N-terminus is Ser 20. The reducing (R) protein migrates as 45-48 kDa in SDS-PAGE due to glycosylation. 产品背景:SERPINE2 is also known as Glia-derived nexin (GDN), Peptidase inhibitor 7 (PI7), Protease nexin 1(PN1). SERPINE2 is a secreted glycoprotein which belongs to the serpin family. SerpinE1 is the primary physiological inhibitor of the two plasminogen activators urokinase (uPA) and tissue plasminogen activator (tPA). PAI-1 / GDN is also implicated in adipose tissue development. It suggests that PAI-1 inhibitors serve in the control of atherothrombosis. Defects in Serpin E1 / PN1 are the cause of plasminogen activator inhibitor-1 deficiency (PAI-1 deficiency) which is characterized by abnormal bleeding due to SerpinE1 defect in the plasma.SDS-PAGE
